106. Nat Commun. 2018 Mar 23;9(1):1219. doi: 10.1038/s41467-018-03631-z.Poly-ligand profiling differentiates trastuzumab-treated breast cancer patientsaccording to their outcomes.Domenyuk V(1), Gatalica Z(1), Santhanam R(1), Wei X(1), Stark A(1), Kennedy P(1),Toussaint B(1), Levenberg S(1), Wang J(1), Xiao N(1), Greil R(2), RinnerthalerG(2), Gampenrieder SP(2), Heimberger AB(3), Berry DA(4), Barker A(5), QuackenbushJ(6), Marshall JL(7), Poste G(1)(5), Vacirca JL(8), Vidal GA(9), SchwartzbergLS(9), Halbert DD(1), Voss A(1), Magee D(1), Miglarese MR(1), FamulokM(10)(11)(12)(13), Mayer G(14)(15)(16), Spetzler D(17).Author information: (1)Caris Life Sciences, 4610 South 44th Place, Phoenix, AZ, 85040, USA.(2)IIIrd Medical Department, Oncologic Center, Paracelsus Medical UniversitySalzburg, Austria and Salzburg Cancer Research Institute, and Cancer ClusterSalzburg, Müllner Hauptstraße, 48A-5020, Salzburg, Austria.(3)Department of Neurosurgery, University of Texas MD Anderson Cancer Center,1400 Holcombe Boulevard, Houston, TX, 77030, USA.(4)Berry Consultants, LLC, 3345 Bee Caves Road, Suite 201, Austin, TX, 78746,USA.(5)Complex Adaptive Systems Initiative, Arizona State University, 1475N.Scottsdale Road, Suite 361, Scottsdale, AZ, 85257, USA.(6)Department of Biostatistics and Computational Biology, Dana-Farber CancerInstitute, 450 Brookline Avenue, Boston, MA, 02215-5450, USA.(7)Department of Oncology, Lombardi Comprehensive Cancer Center, GeorgetownUniversity Medical Center, 3800 Reservoir Road, N.W., Washington, DC, 20057, USA.(8)North Shore Hematology Oncology Associates Cancer Center, 226N Belle MeadRoad, East Setauket, NY, 11733, USA.(9)Division of Hematology and Oncology, University of Tennessee Health ScienceCenter, 7945 Wolf River Boulevard, Memphis, TN, 38138, USA.(10)Caris Life Sciences, 4610 South 44th Place, Phoenix, AZ, 85040, USA.m.famulok@uni-bonn.de.(11)LIMES Program Unit Chemical Biology & Medicinal Chemistry, c/o KekuléInstitute for Organic Chemistry and Biochemistry, University of Bonn,Gerhard-Domagk-Straße 1, 53121, Bonn, Germany. m.famulok@uni-bonn.de.(12)Chemical Biology Max-Planck-Fellowship Group, Center of Advanced EuropeanStudies and Research (CAESAR), Ludwig-Erhard-Allee 2, 53175, Bonn, Germany.m.famulok@uni-bonn.de.(13)Center of Aptamer Research and Development, University of Bonn,Gerhard-Domagk-Straße 1, 53121, Bonn, Germany. m.famulok@uni-bonn.de.(14)Caris Life Sciences, 4610 South 44th Place, Phoenix, AZ, 85040, USA.gmayer@uni-bonn.de.(15)LIMES Program Unit Chemical Biology & Medicinal Chemistry, c/o KekuléInstitute for Organic Chemistry and Biochemistry, University of Bonn,Gerhard-Domagk-Straße 1, 53121, Bonn, Germany. gmayer@uni-bonn.de.(16)Center of Aptamer Research and Development, University of Bonn,Gerhard-Domagk-Straße 1, 53121, Bonn, Germany. gmayer@uni-bonn.de.(17)Caris Life Sciences, 4610 South 44th Place, Phoenix, AZ, 85040, USA.dspetzler@carisls.com.Assessing the phenotypic diversity underlying tumour progression requires theidentification of variations in the respective molecular interaction networks.Here we report proof-of-concept for a platform called poly-ligand profiling (PLP)that surveys these system states and distinguishes breast cancer patients who didor did not derive benefit from trastuzumab. We perform tissue-SELEX on breastcancer specimens to enrich single-stranded DNA (ssDNA) libraries thatpreferentially interact with molecular components associated with the twoclinical phenotypes. Testing of independent sample sets verifies the ability ofPLP to classify trastuzumab-treated patients according to their clinical outcomeswith ROC-AUC of 0.78. Standard HER2 testing of the same patients gives a ROC-AUC of 0.47. Kaplan-Meier analysis reveals a median increase in benefit fromtrastuzumab-containing treatments of 300 days for PLP-positive compared toPLP-negative patients. If prospectively validated, PLP may increase success ratesin precision oncology and clinical trials, thus improving both patient care anddrug development.DOI: 10.1038/s41467-018-03631-z PMCID: PMC5865185PMID: 29572535 